Cargando…

Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization

BACKGROUND: The ALBI-TAE model was recently proposed as a scoring system to select suitable patients with intermediate-stage hepatocellular carcinoma (HCC) for transarterial chemoembolization (TACE). However, this scoring system has not been externally validated. Therefore, we validated this score a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bannangkoon, Kittipitch, Hongsakul, Keerati, Tubtawee, Teeravut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228079/ https://www.ncbi.nlm.nih.gov/pubmed/37248526 http://dx.doi.org/10.1186/s40644-023-00575-6

Ejemplares similares

Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2021)

Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma
por: Bannangkoon, Kittipitch, et al.
Publicado: (2023)

Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study
por: Bannangkoon, Kittipitch, et al.
Publicado: (2023)

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2019)

Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma
por: Bannangkoon, Kittipitch, et al.
Publicado: (2022)

Rate and Predictive Factors for Sustained Complete Response after Selective Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma
por: Bannangkoon, Kittipitch, et al.
Publicado: (2018)

ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2021)

A Severe Case of Median Arcuate Ligament Syndrome with Successful Angioplasty and Stenting
por: Hongsakul, Keerati, et al.
Publicado: (2012)

Paclitaxel-Coated Balloon Angioplasty for Early Restenosis of Central Veins in Hemodialysis Patients: A Single Center Initial Experience
por: Hongsakul, Keerati, et al.
Publicado: (2018)

Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
por: Chi, Chen-Ta, et al.
Publicado: (2021)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Comparison of Overall Survival between Transarterial Chemoembolization and Best Supportive Care in Intermediate-Stage Hepatocellular Carcinoma
por: Akarapatima, Keerati, et al.
Publicado: (2022)

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015)

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
por: Antkowiak, Mark, et al.
Publicado: (2019)

Comparison between Computer Tomography and Magnetic Resonance Imaging in the Diagnosis of Small Hepatocellular Carcinoma
por: Lertpipopmetha, Korn, et al.
Publicado: (2016)

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
por: Zhou, Qunfang, et al.
Publicado: (2020)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Chen, Shuling, et al.
Publicado: (2019)

Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma
por: Shimose, Shigeo, et al.
Publicado: (2020)

The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2021)

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization
por: Liu, Chang, et al.
Publicado: (2018)

Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization
por: Inmutto, Nakarin, et al.
Publicado: (2022)

High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Li, Qiang, et al.
Publicado: (2021)

Latent Class Analysis of Subphenotypes in Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Chen, Siyu, et al.
Publicado: (2022)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

Commentary
por: Hongsakul, Keerati
Publicado: (2014)

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
por: Chu, Hee Ho, et al.
Publicado: (2021)

Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma：A Propensity Score Matching Analysis
por: Qiu, Zhiyu, et al.
Publicado: (2019)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
por: Liu, Furong, et al.
Publicado: (2019)

Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
por: Lu, Linbin, et al.
Publicado: (2021)

Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
por: Lim, Ji Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3e1qt6dcrb03pt7jl5ml4rgug